Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Medical System HoldingsCHSYF +0.11%87 5-Year Yield-on-Cost % is 1.53 as of Jul. 31, 2026, which is 22% below its 10-year median of 1.95. GuruFocus rates CHSYF with a GF Scoreâ„¢ of 87/100 and a GF Valueâ„¢ of $1.30 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 513 Drug Manufacturers companies, China Medical System Holdings ranks worse than 61.79% on this metric.
China Medical System Holdings (OTCPK:CHSYF) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
China Medical System Holdings 5-Year Yield-on-Cost % Related Terms
CHSYF vs ZTS: 5-Year Yield-on-Cost % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, China Medical System Holdings's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Medical System Holdings 5-Year Yield-on-Cost % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China Medical System Holdings's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where China Medical System Holdings's 5-Year Yield-on-Cost % falls into.
China Medical System Holdings 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
China Medical System Holdings (CHSYF) has a 5-Year Yield-on-Cost % of 1.53 as of Jul. 31, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on China Medical System Holdings and its competitors. This is 22% below median its historical median of 1.95. Over the past decade, China Medical System Holdings' 5-Year Yield-on-Cost % has ranged from 0.66 to 5.48. According to the industry distribution chart, China Medical System Holdings ranks #317 out of 513 companies in the Drug Manufacturers industry, placing it in the top 61.8%.
Is China Medical System Holdings' 5-Year Yield-on-Cost % too high?
China Medical System Holdings' current 5-Year Yield-on-Cost % of 1.53 is 22% below median its 10-year median of 1.95. Over the past 10 years, this metric has ranged from a low of 0.66 to a high of 5.48. The Drug Manufacturers industry median 5-Year Yield-on-Cost % is 2.29. China Medical System Holdings' value of 1.53 is 33.2% below this industry median. Based on the distribution chart, China Medical System Holdings ranks #317 out of 513 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, China Medical System Holdings has a GF Scoreâ„¢ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does China Medical System Holdings' 5-Year Yield-on-Cost % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, China Medical System Holdings ranks #317 out of 513 companies for 5-Year Yield-on-Cost %. This places China Medical System Holdings in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.29. China Medical System Holdings' value of 1.53 is 33.2% below this benchmark. Historically, China Medical System Holdings' own 5-Year Yield-on-Cost % has ranged from 0.66 to 5.48 over the past decade. While the company's 10-year median is 1.95 vs. the industry median of 2.29, China Medical System Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.29, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Medical System Holdings's current 5-Year Yield-on-Cost % of 1.53 is 33.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on China Medical System Holdings and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Medical System Holdings's current 5-Year Yield-on-Cost % is 1.53, which is 22% below median its own 10-year median of 1.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Medical System Holdings stock overvalued right now?
Based on GuruFocus' analysis, China Medical System Holdings (CHSYF) is currently considered Modestly Overvalued. The stock's GF Value™ is $1.30, compared to a current price of $1.57 — trading 20.8% above its estimated fair value. The current 5-Year Yield-on-Cost % is 1.53, which is 22% below median its 10-year median of 1.95 and 33.2% below the Drug Manufacturers industry median of 2.29. China Medical System Holdings' overall GF Score™ is 87/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For China Medical System Holdings (CHSYF), the current 5-Year Yield-on-Cost % is 1.53 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Medical System Holdings (CHSYF) Overvalued in 2026?
Based on GuruFocus' analysis, China Medical System Holdings stock appears to be overvalued.
The current stock price of $1.57 is trading 20.8% above its estimated GF Value™ of $1.30.
GuruFocus considers China Medical System Holdings to be Modestly Overvalued.
Key valuation signals for CHSYF:
5-Year Yield-on-Cost %: 1.53 (22% below median its 10-year median of 1.95)
GF Value™: $1.30 vs. price of $1.57 (20.8% above fair value)
Industry Position: 33.2% below the Drug Manufacturers median (#317 of 513)
No single metric tells the full story. See the CHSYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Medical System Holdings Ltd is a holding company. Along with its subsidiaries, it is engaged in the research and development, production, promotion and sale of medicines. The company's reportable segments are: (i) Integrated pharmaceuticals portfolio and (ii) Skin diseases related business. The majority of the company's revenue, which consists of pharmaceutical products sales, is derived from the integrated pharmaceuticals portfolio segment.
87GF Score
Get the complete analysis for CHSYF
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHSYF has been successfully added to your 
